Pallas Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Buy
4,792
+530
+12% +$181K 0.05% 236
2026
Q1
$1.5M Buy
4,262
+458
+12% +$163K 0.06% 246
2025
Q4
$1.25M Sell
3,804
-212
-5% -$67.2K 0.04% 311
2025
Q3
$1.13M Sell
4,016
-55
-1% -$16K 0.04% 316
2025
Q2
$1.14M Sell
4,071
-535
-12% -$152K 0.04% 307
2025
Q1
$1.44M Sell
4,606
-198
-4% -$58.5K 0.06% 234
2024
Q4
$1.25M Sell
4,804
-18,162
-79% -$5.39M 0.05% 196
2024
Q3
$7.25M Sell
22,966
-736
-3% -$241K 0.31% 71
2024
Q2
$7.84M Buy
23,702
+756
+3% +$222K 0.35% 60
2024
Q1
$6.52M Buy
22,946
+1,253
+6% +$367K 0.27% 74
2023
Q4
$6.25M Buy
21,693
+286
+1% +$77.9K 0.33% 61
2023
Q3
$5.63M Buy
21,407
+2,228
+12% +$556K 0.34% 59
2023
Q2
$4.37M Sell
19,179
-83
-0.4% -$19.3K 0.2% 71
2023
Q1
$4.71M Buy
19,262
+1,586
+9% +$389K 0.44% 68
2022
Q4
$4.65M Sell
17,676
-22
-0.1% -$5.9K 0.47% 60
2022
Q3
$4.71M Buy
17,698
+917
+5% +$222K 0.52% 59
2022
Q2
$4.13M Sell
16,781
-938
-5% -$230K 0.57% 52
2022
Q1
$4.5M Buy
17,719
+1,848
+12% +$425K 0.58% 51
2021
Q4
$3.61M Buy
15,871
+991
+7% +$209K 0.44% 54
2021
Q3
$3.25M Buy
14,880
+5,132
+53% +$1.18M 0.36% 65
2021
Q2
$2.23M Buy
9,748
+1,628
+20% +$400K 0.31% 66
2021
Q1
$2.05M Buy
+8,120
New +$1.94M 0.46% 51

Other funds holding AMGN

Pallas Capital Advisors's AMGN Position: Q2 2026 in Review

Pallas Capital Advisors increased its Amgen (AMGN) stake by 12% in Q2 2026, buying an estimated $181K and bringing the position to 4,792 shares worth $1.74M. The position accounts for 0.05% of the portfolio, ranked #236.

Pallas Capital Advisors first reported a position in AMGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $7.84M in Q2 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Pallas Capital Advisors held 4,792 shares of Amgen worth $1.74M as of Q2 2026.
  • Pallas Capital Advisors bought 530 Amgen shares in Q2 2026, an estimated $181K.
  • Amgen made up 0.05% of Pallas Capital Advisors's portfolio in Q2 2026, its #236 holding.
  • Pallas Capital Advisors first reported a position in Amgen in Q1 2021 and has held it in 22 quarters since.
  • Pallas Capital Advisors's Amgen position peaked at $7.84M in Q2 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.